Reaction
Hypertrichosis reporting signals
As of the last recalculation, Hypertrichosis appears in 1,840 FAERS reports alongside 24 co-occurring drug terms. The strongest observed disproportionality signal is MINOXIDIL FOAM 5% (WOMENS) (PRR 115.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Minoxidil Foam 5% (Womens) | 286 | 115.9 | 116.9 |
| Minoxidil | 295 | 88.3 | 88.9 |
| Panitumumab | 44 | 32.5 | 32.6 |
| Levonorgestrel | 285 | 18.8 | 18.8 |
| Clobetasol Propionate Ointment Usp, 0.05% | 10 | 11.0 | 11.0 |
| Abacavir Sulfate | 9 | 10.5 | 10.5 |
| Cyclosporine | 96 | 10.2 | 10.3 |
| Clobetasol Propionate | 9 | 9.9 | 9.9 |
| Cetuximab | 25 | 9.1 | 9.1 |
| Tranexamic Acid | 7 | 8.9 | 8.9 |
| Testosterone | 17 | 8.3 | 8.3 |
| Ritonavir 100 Mg | 10 | 7.6 | 7.6 |
| Darunavir | 9 | 6.8 | 6.8 |
| Voclosporin | 5 | 6.5 | 6.5 |
| Raltegravir | 9 | 6.2 | 6.2 |
| Guanfacine | 4 | 5.8 | 5.8 |
| Vemurafenib | 6 | 5.7 | 5.7 |
| Oxaliplatin | 33 | 5.1 | 5.1 |
| Erlotinib | 4 | 4.7 | 4.7 |
| Bimatoprost | 9 | 3.5 | 3.5 |
| Drospirenone And Ethinyl Estradiol | 11 | 2.8 | 2.8 |
| Somatropin | 18 | 2.8 | 2.8 |
| Copper | 3 | 0.8 | 0.8 |
| Adapalene | 4 | 0.2 | 0.2 |